Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 3:41 pm Purchase | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | STATE STREET CORP STT | 2,571,570 5.390% | 2,571,570 (New Position) | Filing History |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Protagonist Therapeutics, Inc. PTGX | FMR LLC | 6,847,277 14.346% | 394,513 (+6.11%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | BlackRock Inc. BLK | 3,281,636 6.900% | 689,925 (+26.62%) | Filing History |
| 2021-09-21 4:34 pm Purchase | 2021-09-20 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 4,329,030 9.100% | 4,329,030 (New Position) | Filing History |
| 2021-02-17 2:23 pm Sale | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 2,729,709 6.380% | -3,328,796 (-54.94%) | Filing History |
| 2021-02-16 2:22 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Consonance Capital Management LP | 6,058,505 9.990% | 6,058,505 (New Position) | Filing History |
| 2021-02-12 9:17 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | BIOTECHNOLOGY VALUE FUND L P | 4,274,965 9.990% | 1,942,335 (+83.27%) | Filing History |
| 2021-02-12 6:42 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | FARALLON CAPITAL MANAGEMENT LLC | 3,925,000 9.000% | 1,071,902 (+37.57%) | Filing History |
| 2021-02-12 09:36 am Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW Investments, LP | 3,650,069 8.670% | 1,190,081 (+48.38%) | Filing History |
| 2021-02-11 08:05 am Sale | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,150,045 2.690% | -1,049,955 (-47.73%) | Filing History |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Protagonist Therapeutics, Inc. PTGX | FMR LLC | 6,452,764 15.079% | 2,371,797 (+58.12%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | BlackRock Inc. BLK | 2,591,711 6.200% | 935,470 (+56.48%) | Filing History |
| 2021-02-01 5:41 pm Unchanged | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | JOHNSON & JOHNSON JNJ | 2,449,183 5.700% | 0 (Unchanged) | Filing History |